Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
US7022485B1 · kind B1 · utility
3Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2000 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | Jun 30, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/102
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns citrulline polypeptide derived from fibrin useful for diagnosing or treating rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.